LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

Search

Evolent Health Inc

Geschlossen

BrancheGesundheitswesen

4.01 0.75

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.92

Max

4.1

Schlüsselkennzahlen

By Trading Economics

Einkommen

30M

-21M

Verkäufe

35M

480M

Gewinnspanne

-4.351

Angestellte

4,500

EBITDA

512K

15M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+154.14% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-302M

478M

Vorheriger Eröffnungskurs

3.26

Vorheriger Schlusskurs

4.01

Nachrichtenstimmung

By Acuity

40%

60%

119 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Evolent Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Dez. 2025, 23:54 UTC

Wichtige Markttreiber

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

22. Dez. 2025, 19:08 UTC

Akquisitionen, Fusionen, Übernahmen

Correction to Alphabet to Buy Intersect Article

22. Dez. 2025, 17:21 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

22. Dez. 2025, 16:46 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Buy Intersect for $4.75 Billion in Cash

22. Dez. 2025, 23:50 UTC

Market Talk

Nikkei May Decline as Yen Rebounds -- Market Talk

22. Dez. 2025, 23:42 UTC

Market Talk

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

22. Dez. 2025, 22:31 UTC

Ergebnisse

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

22. Dez. 2025, 22:31 UTC

Ergebnisse

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

22. Dez. 2025, 22:30 UTC

Ergebnisse

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

22. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. Dez. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

22. Dez. 2025, 21:37 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

22. Dez. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

22. Dez. 2025, 21:35 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn to Acquire Prospective Package From Tempest Minerals

22. Dez. 2025, 21:35 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

22. Dez. 2025, 20:54 UTC

Akquisitionen, Fusionen, Übernahmen

Middle West Partners Buys Paul Stuart From Mitsui & Co.

22. Dez. 2025, 20:52 UTC

Akquisitionen, Fusionen, Übernahmen

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

22. Dez. 2025, 20:09 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

22. Dez. 2025, 19:56 UTC

Market Talk

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

22. Dez. 2025, 19:49 UTC

Akquisitionen, Fusionen, Übernahmen

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

22. Dez. 2025, 19:23 UTC

Market Talk

Mexico's Inflation Seen Easing in Early December -- Market Talk

22. Dez. 2025, 19:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. Dez. 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

22. Dez. 2025, 19:02 UTC

Market Talk

Precious Metals Climb to New Heights -- Market Talk

22. Dez. 2025, 18:45 UTC

Market Talk

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

22. Dez. 2025, 18:30 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

22. Dez. 2025, 18:23 UTC

Akquisitionen, Fusionen, Übernahmen

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

22. Dez. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

22. Dez. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

22. Dez. 2025, 17:06 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Peer-Vergleich

Kursveränderung

Evolent Health Inc Prognose

Kursziel

By TipRanks

154.14% Vorteil

12-Monats-Prognose

Durchschnitt 10.14 USD  154.14%

Hoch 16 USD

Tief 7 USD

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Evolent Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

13 ratings

13

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

10.33 / 10.95Unterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

119 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat